Cargando…
Proteome-based insights for IDH-mutant glioma classification
In this issue, Bader et al.(1) characterize the proteomes of diffuse glioma brain tumors by liquid chromatography mass spectrometry and classify isocitrate dehydrogenase (IDH)-mutant gliomas into two subtypes, which differ in oncogenic pathways and aerobic/anaerobic energy metabolism.
Autores principales: | Leu, Severina, Hutter, Gregor, Boulay, Jean-Louis |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9873937/ https://www.ncbi.nlm.nih.gov/pubmed/36652918 http://dx.doi.org/10.1016/j.xcrm.2022.100909 |
Ejemplares similares
-
Mutant HER2 needs mutant HER3 to be an effective oncogene
por: Trenker, Raphael, et al.
Publicado: (2021) -
SARS Proteomics Reveals Viral Secrets
por: Garman, Elspeth
Publicado: (2005) -
Spatially resolved proteomics identify biomarkers from endometrial sentinel lymph nodes
por: Li, Renliang, et al.
Publicado: (2021) -
Genomic discoveries unveil mechanistic insights in diabetes
por: Florez, Jose C.
Publicado: (2022) -
The human pangenome reference anticipates equitable and fundamental genomic insights
por: Frazer, Kelly A., et al.
Publicado: (2023)